NSEUpdates7 Oct 2026 · 7 Oct 2026, 12:15 am
Updates
BALAXI PHARMACEUTICALS LIMITED · BALAXI
✦ AI Summary
Balaxi Pharmaceuticals has informed the Exchange regarding the re-lodgement of transfer requests of physical shares for the period ended September 2026, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated 30th January, 2026.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding ''RTA Report for Re-lodgement of Transfer Requests of Physical Shares for the period ended September 2026."
Attachments (1)
📄pdf
Download →
BALAXI_07102026001312_NSE_Announcement_07102026.pdf
View document text
Date: 07th October, 2026
Listing Department,
National Stock Exchange of India Limited
Exchange Plaza, Plot No C-1, Block G, Bandra Kurla Complex,
Bandra (E), Mumbai – 400051
NSE Symbol: BALAXI
Subject: RTA Report on Re-Lodgement of Transfer Requests of Physical Shares as per
SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated 30th January,
2026.
Dear Sir / Madam,
In terms of SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated
30th January, 2026, we are enclosing herewith the Report for the period ended
September 2026, received from M/s. Aarthi Consultants Private Limited, the Registrar and
Share Transfer Agent of the Company, regarding the re-lodgement of transfer requests of
physical shares.
The same will also be available on the Company’s website at www.balaxipharma.in
This is for your information and record.
Thanking You.
Yours faithfully,
For Balaxi Pharmaceuticals Limited
Aman Purohit
(Company Secretary & Compliance Officer)
ICSI Membership No.: A59345
(Encl: As above)
arthi Consultants Private Limited
Categ:osy I R&gi trars, & Stiare Tr.an fer Aigents.-SEBI Reg1n. No; INIRBOSEJ00319
CIN· U7-414DTG1992PTC0140-44. GST No,: 3:6,AABCA6520H1ZZ
To, Date: 06/10/2026
The Company Secretary
BALAXI PHARMACEUTICALS LIMITED
Reg.Offi:Plot No.409,H.No.8-2-293
MAPS Towers,3rd Floor,Phase-III
Road No.81,Jubilee Hills
Hyderabad,Telangana 500096
Dear Sir/Madam,
Subject: Intimation on Receipt of Request for Re-Lodgement of Tranfer Requests of Physical Shares as
per SEBI Circular No.SEBI/HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 Dated 30th January, 2026.
We hereby confirm the status below as of September,2026 regarding requests received
from shareholders for the re-lodgement of transfer requests for physical shares under the
special window provided by the SEBI Circular dated 30th January, 2026.
No. of No. of No. of No. of Average time
requests requests requests requests taken for
received processed approved rejected processing of
during during during during requests (in
the month the month the month the month days)
NIL NIL NIL NIL NA
The above is for your information and intimation to the Stock Exchanges.
Thanking You
Yours faithfully
For AARTHI CONSULTANTS PVT LTD
Jagan Mohan Gobburi
Compliance Officer
# 1-2-265, Oomalguda, Hyderabad -500 029.
Phones: 2763 8111, 2763 4445, 2764 2217, 6661 1921, Fax: (91-40) 27632164
E-mail; info@aarthiconsultants.com, Visit us at: www.aarthiconsuttants.com